Abstract
Renal cell carcinoma of the clear cell type (ccRCC) is associated with loss of functional von Hippel–Lindau (VHL) protein and high, homogeneous expression of the G250MN protein, an isoenzyme of the carbonic anhydrase family. High expression of G250MN is found in all ccRCCs, but not in most normal tissues, including normal human kidney. We specifically studied the mechanism of transcriptional regulation of the CAIXG250 gene in RCC. Previous studies identified Sp1 and hypoxia-inducible factor (HIF) as main regulatory transcription factors of G250MN in various non-RCC backgrounds. However, G250MN regulation in RCC has not been studied and may be differently regulated in view of the HIF accumulation under normoxic conditions due to VHL mutations. Transient transfection of different G250MN promoter constructs revealed strong promoter activity in G250MN -positive RCC cell lines, but no activity in G250MN -negative cell lines. DNase-I footprint and band-shift analysis demonstrated that Sp1 and HIF-1α proteins in nuclear extracts of RCC cells bind to the CAIX promoter and mutations in the most proximal Sp1 binding element or HIF binding element completely abolished CAIX promoter activity, indicating their critical importance for the activation of G250 expression in RCC. A close correlation between HIF-1α expression and G250MN expression was observed. In contrast, no relationship between HIF-2α expression and G250MN was seen. The participation of cofactor CBP/p300 in the regulation of G250 transcription was shown. In conclusion, HIF-1α and Sp1, in combination with CBP/p300, are crucial elements for G250MN expression in ccRCC, and CAIXG250 can be regarded as a unique HIF-1α target gene in ccRCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- CAIX:
-
G250 gene
- ccRCC:
-
clear cell renal cell carcinoma
- EMSA:
-
electrophoretic mobility shift assay
- G250:
-
G250CAIX/MN
- HIF:
-
hypoxia-inducible factor
- HGH:
-
human growth hormone
- HRE:
-
hypoxia-responsive element
- HSV-tk:
-
herpes simplex virus-thymidine kinase
- NE:
-
nuclear extract
- PCR:
-
polymerase chain reaction
- TF:
-
transcription factor
- VHL:
-
von Hippel–Lindau
References
Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF and Livingston DM . (1996). Proc. Natl. Acad. Sci. USA, 93, 12969–12973.
Beasley NJ, Wykoff CC, Watson PH, Leek R, Turley H, Gatter K, Pastorek J, Cox GJ, Ratcliffe P and Harris AL . (2001). Cancer Res., 61, 5262–5267.
Bockamp EO, Fordham JL, Gottgens B, Murrell AM, Sanchez MJ and Green AR . (1998). J. Biol. Chem., 273, 29032–29042.
Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA and Belldegrun AS . (2003). Clin. Cancer Res., 9, 802–811.
Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H and Poellinger L . (2000). Mol. Cell. Biol., 20, 402–415.
Clifford SC, Astuti D, Hooper L, Maxwell PH, Ratcliffe PJ and Maher ER . (2001). Oncogene, 20, 5067–5074.
Ebert T, Bander NH, Finstad CL, Ramsawak RD and Old LJ . (1990). Cancer Res., 50, 5531–5536.
Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, Acker T, Rauter M, Plate K, Sieweke M, Breier G and Flamme I . (2003). J. Biol. Chem., 278, 7520–7530.
Gothie E, Richard DE, Berra E, Pages G and Pouyssegur J . (2000). J. Biol. Chem., 275, 6922–6927.
Grabmaier K, Vissers JL, De Weijert MC, Oosterwijk-Wakka JC, Van Bokhoven A, Brakenhoff RH, Noessner E, Mulders PA, Merkx G, Figdor CG, Adema GJ and Oosterwijk E . (2000). Int. J. Cancer, 85, 865–870.
Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR and Linehan WM . (1994). Proc. Natl. Acad. Sci. USA, 91, 9700–9704.
Hu CJ, Wang LY, Chodosh LA, Keith B and Simon MC . (2003). Mol. Cell. Biol., 23, 9361–9374.
Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI and Stanbridge EJ . (2001). Am. J. Pathol., 158, 905–919.
Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA and van der Kogel AJ . (2002). Cancer Res., 62, 7066–7074.
Kaluzova M, Pastorekova S, Svastova E, Pastorek J, Stanbridge EJ and Kaluz S . (2001). Biochem. J., 359, 669–677.
Kaluz S, Kaluzova M, Opavsky R, Pastorekova S, Gibadulinova A, Dequiedt F, Kettmann R and Pastorek J . (1999). J. Biol. Chem., 274, 32588–32595.
Kaluz S, Kaluzova M and Stanbridge EJ . (2003). Cancer Res., 63, 917–922.
Liu Z and Simpson ER . (1999). Mol. Cell. Endocrinol., 153, 183–196.
Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ and West CM . (2001). Cancer Res., 61, 6394–6399.
Mandriota SJ, Turner KJ, Davies DR, Murray PG, Morgan NV, Sowter HM, Wykoff CC, Maher ER, Harris AL, Ratcliffe PJ and Maxwell PH . (2002). Cancer Cell, 1, 459–468.
Martinez A, Fullwood P, Kondo K, Kishida T, Yao M, Maher ER and Latif F . (2000). Mol. Pathol., 53, 137–144.
Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ . (1999). Nature, 399, 271–275.
Michel G, Minet E, Mottet D, Remacle J and Michiels C . (2002). Biochim. Biophys. Acta, 1578, 73–83.
Motzer RJ, Bander NH and Nanus DM . (1996). N. Engl. J. Med., 335, 865–875.
Oosterwijk E, Ruiter DJ, Hoedemaeker PJ, Pauwels EK, Jonas U, Zwartendijk J and Warnaar SO . (1986). Int. J. Cancer, 38, 489–494.
Opavsky R, Pastorekova S, Zelnik V, Gibadulinova A, Stanbridge EJ, Zavada J, Kettmann R and Pastorek J . (1996). Genomics, 33, 480–487.
Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S and Eckardt KU . (2002). J. Am. Soc. Nephrol., 13, 1721–1732.
Sambrook J and Russell DW . (2001). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
Sang N, Fang J, Srinivas V, Leshchinsky I and Caro J . (2002). Mol. Cell. Biol., 22, 2984–2992.
Suzuki T, Kimura A, Nagai R and Horikoshi M . (2000). Genes Cells, 5, 29–41.
Thrash-Bingham CA and Tartof KD . (1999). J. Natl. Cancer Inst., 91, 143–151.
Uemura H, Nakagawa Y, Yoshida K, Saga S, Yoshikawa K, Hirao Y and Oosterwijk E . (1999). Br. J. Cancer, 81, 741–746.
Verhaegh GW, Van Bokhoven A, Smit F, Schalken JA and Bussemakers MJ . (2000). J. Biol. Chem., 275, 37496–37503.
Vet JA, Hessels D, Marras SA, van de Kaa CA, van der Poel HG, Michalides RJ, Debruyne FM and Schalken JA . (1998). Am. J. Clin. Pathol., 110, 647–652.
Wiesener MS, Munchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jurgensen JS, Gruber G, Maxwell PH, Loning SA, Frei U, Maher ER, Grone HJ and Eckardt KU . (2001). Cancer Res., 61, 5215–5222.
Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL . (2000). Cancer Res., 60, 7075–7083.
Acknowledgements
This work was supported by a grant from the Dutch Cancer Society (Grant no. KUN 96-1345). EO was supported by the Ludwig Institute for Cancer Research, New York.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grabmaier, K., de Weijert, M., Verhaegh, G. et al. Strict regulation of CAIXG250/MN by HIF-1α in clear cell renal cell carcinoma. Oncogene 23, 5624–5631 (2004). https://doi.org/10.1038/sj.onc.1207764
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207764
Keywords
This article is cited by
-
Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments
Cancer Cell International (2020)
-
MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells
Cellular & Molecular Biology Letters (2019)
-
Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion
Oncogene (2018)
-
Profiling of the metabolic transcriptome via single molecule molecular inversion probes
Scientific Reports (2017)
-
Transcription factor HIF1A: downstream targets, associated pathways, polymorphic hypoxia response element (HRE) sites, and initiative for standardization of reporting in scientific literature
Tumor Biology (2016)